FDA Bact-Away coverage for business development, investment, and market access teams
The FDA has approved Bact-Away, a groundbreaking antibiotic designed to combat resistant infections, marking a significant advancement in antibiotic therapy.
We use cookies to enhance your experience, analyze traffic, and for marketing. By continuing to use our site, you consent to our use of cookies. Privacy Policy
